Genetron Holdings Ltd.
(NASDAQ : GTH)

( )
GTH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
GHGuardant Health, Inc. -0.18%119.990.0%$125.86m
OSHOak Street Health, Inc. 4.41%58.520.0%$121.91m
NTRANatera, Inc. 6.24%109.301.2%$108.12m
NVTAInvitae Corp. 1.68%33.341.2%$106.03m
LFSTLifestance Health Group, Inc. -0.84%25.990.0%$95.73m
DVADaVita, Inc. 2.17%124.273.7%$67.25m
SDCSmileDirectClub, Inc. 3.04%9.140.0%$66.70m
FLGTFulgent Genetics, Inc. 1.74%78.770.6%$54.90m
AMEDAmedisys, Inc. 2.71%245.4411.4%$51.25m
ONEM1Life Healthcare, Inc. 2.63%34.770.0%$50.46m
AGLAgilon Health, Inc. -2.66%42.100.0%$39.29m
CHEChemed Corp. 1.96%479.4710.1%$33.93m
OPCHOption Care Health, Inc. 4.23%21.430.0%$32.20m
LHCGLHC Group, Inc. 1.83%200.742.9%$29.99m
NEONeoGenomics, Inc. 2.02%43.995.3%$23.67m

Company Profile

Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.